We are live on ! Find out more
HM

HCC Manager Portfolio holdings

AUM $10.3M Turnover 0%
1-Year Est. Return 6.8%
This Fund
S&P 500
This Quarter Est. Return
-29.33%
1 Year Est. Return
+6.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
–
Cap. Flow
+$195M
Cap. Flow %
111.82%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
NARI icon
Inari Medical
NARI
+$156M
2
GUTS icon
Fractyl Health
GUTS
+$39.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NARI icon
1
DELISTED
Inari Medical
NARI
$140M 80.17%
+2,914,246
New +$156M
2024 Q1
0 quarters
GUTS icon
2
Fractyl Health
GUTS
$10.9M
$34.6M 19.83%
+389,489
New +$39.3M
2024 Q1
0 quarters

Similar funds

HCC Manager's Q1 2024 Portfolio in Review

Q1 2024 is the first quarter with a 13F filing on record for HCC Manager, which disclosed 2 positions worth $174M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Inari Medical: 2,914,246 shares worth $140M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • HCC Manager's largest Q1 2024 buy was Inari Medical: 2,914,246 shares worth $140M.
  • HCC Manager's ten largest holdings make up 100% of its $174M portfolio in Q1 2024.
  • HCC Manager disclosed 2 positions in Q1 2024, its first 13F filing on record.

Based on HCC Manager's 13F filing for Q1 2024, filed 10 May 2024.